-
Upsher-Smith previews expansion of rare disease portfolio at 2024 AAN annual meeting
Upsher-Smith has broadened its offerings to include Vigadrone (vigabatrin) Tablets, 500 mg. Torpenz Tablets, a branded-generic everolimus tablet, will soon be available to prescribers and patients. -
Murad's refillable product launch focuses on sustainability
The Retinal ReSculpt Overnight Treatment and Cellular Hydration Barrier Repair Serum refills help lessen packaging materials by up to 85%, the company said.